{
    "nct_id": "NCT06395441",
    "official_title": "Phase III Study of Ginseng for Cancer Related Fatigue",
    "inclusion_criteria": "* Age ≥ 18 years\n* History of cancer-related fatigue as defined by an average score ≥ 4 over the past 30 days on the numeric analogue scale. Patients can answer questions orally rather than completing worksheet\n* Baseline control of insomnia: Insomnia ≤ 4 on Linear Analogue Scale. Patients can answer questions orally rather than completing worksheet\n* Baseline control of pain: Pain ≤ 4 on Linear Analogue Scale. Patients can answer questions orally rather than completing worksheet\n* Life expectancy ≥ 6 months\n* Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2\n* Hemoglobin ≥ 10.0 g/dL (patients must not have been transfused in the preceding 90 days to meet this criterion) (≤ 180 days prior to registration)\n* Alanine aminotransferase (ALT) or aspartate transaminase (AST) ≤ 3 x upper limit normal (ULN) (≤ 180 days prior to registration)\n* Creatinine ≤ 1.5 x ULN (≤ 180 days prior to registration)\n* No clinical suspicion of hypothyroidism within 180 days prior to registration [if clinical suspicion of hypothyroidism exists, a documented thyroid stimulating hormone (TSH) < 5 milli-international units per liter (mIU/L) is required]\n* Negative pregnancy test done ≤ 7 days prior to registration, for persons of childbearing potential only\n* Ability to complete questionnaire(s) by themselves or with assistance\n* Provide informed consent\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Any known hypersensitivity to ginseng\n* Currently using any other pharmacologic agents to specifically treat fatigue including psychostimulants or antidepressants. Note: Antidepressants used to treat items other than fatigue (such as hot flashes or depression) are allowed if the patient has been on a stable dose for ≥ 30 days and plan to continue such for 8 weeks. Exercise is allowed\n* Psychiatric disorder such as poorly controlled depression, manic depressive disorder, obsessive compulsive disorder, or schizophrenia (defined per medical history)\n* Use of erythropoietic agents ≤ 6 months\n* Uncontrolled hypertension on more than three occasions (diastolic blood pressure ≥ 100, systolic ≥ 160) measured ≤ 180 days prior to randomization\n* Surgery that required general anesthetic ≤ 30 days prior to randomization\n* Malnutrition, active infection, severe depression, or significant pulmonary disease and cardiovascular disease (as determined by the attending clinician), as they could impact fatigue\n* Use of any over the counter herbal/dietary supplement marketed for fatigue or energy (for example, products containing any type of ginseng, Rhodiola rosea, guarana, or anything called an \"adaptogen\")\n* Currently using an antidiabetic drug, warfarin or monamine oxide inhibitor\n* Treating provider anticipates a change to the anti-cancer treatment program in the next 8 weeks (i.e., the intervention period)",
    "miscellaneous_criteria": ""
}